Comparison of chloroform-induced toxicity in the kidneys, liver, and nasal passages of male Osborne-Mendel and F-344 rats

Cancer Letters

Volumn 104, Issue 1, 1996, Pages 71-78

  Templin, Michael V ^a   Jamison, Keith C ^a   Wolf, Douglas C ^a   Morgan, Kevin T ^a   Butterworth, Byron E ^a  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

Cell proliferation; Chloroform; F 344 rat; Kidney; Osborne Mendel rat

Indexed keywords

BROXURIDINE; CHLOROFORM; CORN OIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; CYTOTOXICITY; EDEMA; EPITHELIUM CELL; HISTOPATHOLOGY; KIDNEY CANCER; KIDNEY PROXIMAL TUBULE; LABELING INDEX; LIVER CELL; LIVER TOXICITY; MALE; NEPHROTOXICITY; NONHUMAN; NOSE CAVITY; PRIORITY JOURNAL; RAT;

ANIMALIA; ZEA MAYS;

EID: 0029885106     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04234-6     Document Type: Article

References (25)

1. Butterworth, B.E., Popp, J.A., Conolly, R.B. and Goldsworthy, T.L. (1992) Chemically-induced cell proliferation in carcinogenesis. In: Mechanisms of Carcinogenesis in Risk Identification, pp. 279-305. Editors: H. Vainio, P.N. Magee, D.B. McGregor and A.J. McMichael. IARC Scientific Publication Number 116.
2. Corley, R.A., Mendrala, A.L., Smith, F.A., Staats, D.A., Gargas, M.L., Conolly, R.B., Andersen, M.E. and Reitz, R.H. (1990) Development of a physiologically based pharmacokinetic model for chloroform. Toxicol. Appl. Pharmacol., 103, 512-527.
3. 3H]thymidine administered by injection or osmotic pump. Carcinogenesis, 11, 2245-2251.
4. International Programme on Chemical Safety (1994) Chloroform, Environmental Health Criteria 163, World Health Organization, Geneva.
5. Jorgenson, T.A., Meierhenry, E.F., Rushbrook, C.J., Bull, R.J. and Robinson, M. (1985) Carcinogenicity of chloroform in drinking water to male Osborne-Mendel rats and female B6C3F1 mice. Fund. Appl. Toxicol., 5, 760-769.
6. Larson, J.L., Wolf, D.C. and Butterworth, B.E. (1993) The acute hepatotoxic and nephrotoxic effects of chloroform in male F-344 rats and female B6C3F1 mice. Fundam. Appl. Toxicol., 20, 302-315.
7. 1 mice given chloroform by gavage. Fundam. Appl. Toxicol., 23, 537-543.
8. 1 mice and male F-344 rats. Fundam. Appl. Toxicol., 22, 431-446.
9. 1 mice: Comparison of administration by gavage in corn oil vs. ad libitum in drinking water. Fundam. Appl. Toxicol., 22, 90-102.
10. Larson, J.L., Wolf, D.C. and Butterworth, B.E. (1995a) Induced regenerative cell proliferation in the livers and kidneys of male F-344 rats given chloroform in corn oil by gavage or ad libitum in drinking water. Toxicology, 95, 73-86.
11. Larson, J.L., Wolf, D.C., Méry, S., Morgan, K.T. and Butterworth, B.E. (1995b) Toxicity and cell proliferation in the liver, kidneys and nasal passages of female F-344 rats, induced by chloroform administered by gavage. Food Chem. Toxicol., 33, 443-456.
12. Larson, J.L., Templin, M.V., Wolf, D.C., Jamison, K.C., Leininger, J.R., Méry, S., Morgan, K.T., Wong, B.A., Conolly, R.B. and Butterworth, B.E. (1996) A 90-day chloroform inhalation study in female and male B6C3F1 mice: Implications for cancer risk assessment. Fundam. Appl. Toxicol., in press.
13. 1 mice following a 1-week inhalation exposure. Toxicol. Appl. Pharmacol., 125, 214-227.
14. Monticello, T.M., Morgan, K.T. and Hurtt, M.E. (1990) Unit length as the denominator for quantification of cell proliferation in nasal epithelium. Toxicol. Pathol., 18, 24-31.
15. Morgan, K.T., Kimbell, J.S., Monticello, T.M., Patra, A.L. and Fleishman, A. (1991) Studies of inspiratory airflow patterns in the nasal passages of the F344 rat and rhesus monkey using nasal molds: relevance to formaldehyde toxicity. Toxicol. Appl. Pharmacol., 110, 223-240.
16. National Cancer Institute (1976) Carcinogenesis Bioassay of Chloroform, Bethesda, MD, National Tech. Inform. Service No. PB264018/AS.
17. National Institutes of Health (1985) Guide for the care and use of laboratory animals, U.S. Department of Health and Human Services, Public Health Service, NIH Publication No. 86-23.
18. Reitz, R.H., Mendrala, A.L., Corley, R.A., Quast, J.F., Gargas, M.L., Andersen, M.E., Staats, D.A. and Conolly, R.B. (1990) Estimating the risk of liver cancer associated with human exposures to chloroform. Toxicol. Appl. Pharmacol., 105, 443-459.
19. Rosenthal, S.L. (1987) A review of the mutagenicity of chloroform. Environ. Mol. Mutagenesis, 10, 211-216.
20. Staats, D.A., King, G.A. and Conolly, R.B. (1990) Effects of aging on chloroform metabolism and tissue solubility. In 1989 Toxic Hazards Research Unit Annual Report (R.S. Kutzman et al., Eds.), 1989 Annual Report for Harry G. Armstrong Aerospace Medical Research Laboratory, Wright-Patterson Air Force Base, pp. 151-160. NSI Technology Services Corporation, Dayton, OH.
21. 1 mice. The Toxicologist, in press.
22. Templin, M.V., Larson, J.L., Butterworth, B.E., Jamison, K.C., Leininger, J.R., Mery, S., Morgan, K.T., Wong, B.A., Conolly, R.B. and Wolf, D.C. (1996b) A 90-day chloroform inhalation study in F-344 rats: profile and relevance to bioassay results. Fundam. Appl. Toxicol., submitted.
23. Williams, D.A. (1971) A test for differences between treatment means when several dose levels are compared with a zero dose control. Biometrics, 27, 103-117.
24. Williams, D.A. (1972). The comparison of several dose levels with a zero dose control. Biometrics, 28, 519-531.
25. 1 mice (abstract), Proc 53rd Annual Meeting of the Japanese Cancer Association.